Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 009290321 approvals29 trials

KWANGDONG PHARMACEUTICAL CO.,LTD

Official website

Kwangdong Pharmaceutical, founded in 1963 and KOSPI-listed in 1989, manufactures prescription drugs and beverages.

As of 2026-10-10, KWANGDONG PHARMACEUTICAL CO.,LTD has 4 Korean MFDS device approvals, 317 Korean MFDS drug approvals, 6 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1963 and listed on KOSPI in 1989, Kwangdong Pharmaceutical manufactures and sells prescription drugs and food and beverage products. It operates a roughly 15,000-pyeong food plant in Jangdang-dong, Pyeongtaek, and a roughly 3,000-pyeong GMP plant in Mogok-dong, Pyeongtaek, with some products manufactured via OEM. 98.6% of its revenue comes from the domestic market; it has no license-out agreements but has license-in agreements in place.

Regulatory approvals

data.go.kr

317 Korean MFDS drug approvals · 1963–2026 / 4 Korean MFDS device approvals · 1999–2014

  • MFDS drugK-Acne cream2026-09-21
    Drug · OTC · Notification202602829
  • MFDS drugElfabrio injection(Pegunigalsidase alfa)2026-05-21
    Drug · Prescription · Approval202601480
  • MFDS drugK-tinib Tablet 80mg (Osimertinib mesylate)2026-04-30
    Drug · Prescription · Approval202601294
  • MFDS drugK-tinib Tablet 40mg (Osimertinib mesylate)2026-04-30
    Drug · Prescription · Approval202601295
  • MFDS drugBromfenix Eye Drops2026-02-12
    Drug · Prescription · Approval202600427
  • MFDS drugLamzede injection10mg(Velmanase alfa)2026-01-12
    Drug · Prescription · Approval202600088
  • MFDS drugChondro Power1200 oral gel2025-12-11
    Drug · OTC · Notification202503258
  • MFDS drugKwangdongcold S solution2025-06-24
    Drug · OTC · Notification202501561
  • MFDS drugOLOnyx Eye Drops 0.7%2025-05-26
    Drug · Prescription · Approval202501293
  • MFDS drugGearcare Tab.2025-05-08
    Drug · OTC · Approval202501129
  • MFDS drugOLOnyx Eye Drops 0.2%2025-04-30
    Drug · Prescription · Approval202501057
  • MFDS drugMy Mg Double Care Solution2025-04-24
    Drug · OTC · Notification202500979
Show 68 more
  • MFDS drugBalentok Nail Lacquer2025-04-07
    Drug · OTC · Notification202500819
  • MFDS drugKwangdong Cal-D Tab.2025-03-18
    Drug · OTC · Notification202500617
  • MFDS drugKwangdong L-Arginine Hydrochloride Bag Inj.2024-12-18
    Drug · Prescription · Approval202402996
  • MFDS drugEYETOK Duo eye drops2024-06-25
    Drug · OTC · Approval202401528
  • MFDS drugJangi The Lac Capsule2024-03-26
    Drug · OTC · Notification202400655
  • MFDS drugJangi The Lac Powder2024-03-26
    Drug · OTC · Notification202400656
  • MFDS drugHardyCoPlus Tab.2023-11-27
    Drug · OTC · Notification202303224
  • MFDS drugCoxduo tab.2023-08-10
    Drug · Prescription · Approval202302408
  • MFDS drugEyetok CMC Eye Drops 1%2023-07-28
    Drug · OTC · Notification202302282
  • MFDS drugKwangdong Povidone Iodine Gargle2023-07-07
    Drug · OTC · Approval202302073
  • MFDS drugMymegaPlus Tab.2023-06-22
    Drug · OTC · Notification202301912
  • MFDS drugEYETOK Cool eyedrops2023-05-26
    Drug · OTC · Notification202301685
  • MFDS drug광동침옥고2023-05-11
    Drug · OTC · Approval202301522
  • MFDS drugAlency Cap. 75mg2023-03-22
    Drug · Prescription · Approval202300993
  • MFDS drugAlency Cap. 100mg2023-03-22
    Drug · Prescription · Approval202300994
  • MFDS drugAlency Cap. 125mg2023-03-22
    Drug · Prescription · Approval202301001
  • MFDS drugDacomsita Tablet 10/100mg2023-01-31
    Drug · Prescription · Approval202300417
  • MFDS drugMagnophen Tab2023-01-11
    Drug · OTC · Notification202300204
  • MFDS drugEYEPLE Clear eye drops.2022-12-16
    Drug · OTC · Notification202204515
  • MFDS drugEYEPLE Blue eye drops.2022-12-16
    Drug · OTC · Notification202204516
  • MFDS drugEYEPLE Cure eye drops2022-12-16
    Drug · OTC · Notification202204517
  • MFDS drugDaprodi Tablet 5mg2022-12-05
    Drug · Prescription · Approval202204370
  • MFDS drugKwangdong Chiol Paste(Hinokitiol)2022-11-18
    Drug · OTC · Approval202204148
  • MFDS drugHadicol Q Tab.2022-10-07
    Drug · OTC · Notification202203789
  • MFDS drugIFRISI Tablet2022-06-13
    Drug · Prescription · Approval202202479
  • MFDS drugibuK injection(ibuprofen)2022-06-07
    Drug · Prescription · Approval202202347
  • MFDS drugAmipartibag injection 3%2022-06-02
    Drug · Prescription · Notification202202325
  • MFDS drugEsleesi Tab.2022-05-25
    Drug · Prescription · Approval202202234
  • MFDS drugDaprodi Tablet 10mg2022-05-23
    Drug · Prescription · Approval202202180
  • MFDS drugKwangdong Eneric tab.2022-03-28
    Drug · OTC · Approval202201218
  • MFDS drugKwangdong Meposita tab. 50/850mg2022-01-19
    Drug · Prescription · Approval202200316
  • MFDS drugKwangdong Meposita tab. 50/500mg2022-01-19
    Drug · Prescription · Approval202200317
  • MFDS drugKwangdong Meposita tab. 50/1000mg2022-01-19
    Drug · Prescription · Approval202200318
  • MFDS drugSunhana tab.2021-12-03
    Drug · OTC · Notification202107800
  • MFDS drugKwangdong Piroen soft extract2021-11-10
    Drug · OTC · Notification202107393
  • MFDS drugHardicol Max Tab.2021-08-25
    Drug · OTC · Notification202106150
  • MFDS drugKwangdong Empaglo tab. 25mgRevoked2021-07-29
    Drug · Prescription · Approval202105607
  • MFDS drugKwangdong Empaglo tab. 10mgRevoked2021-07-29
    Drug · Prescription · Approval202105608
  • MFDS drugDualFamo tab.2021-07-09
    Drug · OTC · Notification202105229
  • MFDS drugRinello tab.15mgRevoked2021-03-16
    Drug · Prescription · Approval202102368
  • MFDS drugRinello tab.10mgRevoked2021-03-16
    Drug · Prescription · Approval202102369
  • MFDS drugSolpyo Woo Hwang Chung Sim Won Liquid(including L-Muscone instead of Musk)Revoked2021-01-04
    Drug · OTC · Notification202100019
  • MFDS drugKwangdong Albendazole Tab.Revoked2020-11-26
    Drug · OTC · Notification202008246
  • MFDS drugQ-Acne Plus Cream2020-11-16
    Drug · OTC · Notification202007900
  • MFDS drugHyalsix Inj.2020-10-30
    Drug · Prescription · Approval202007475
  • MFDS drugEYETOK CARE Eye Drops (single use)Revoked2020-10-15
    Drug · OTC · Notification202007061
  • MFDS drug네비레트엠정1.25밀리그램(네비보롤염산염)2020-09-28
    Drug · Prescription · Approval202006679
  • MFDS drug네비레트엠정5밀리그램(네비보롤염산염)2020-09-28
    Drug · Prescription · Approval202006680
  • MFDS drug네비레트엠정2.5밀리그램(네비보롤염산염)2020-09-28
    Drug · Prescription · Approval202006681
  • MFDS drugSolpyo Woohwangchungsimwon Sol. (replace Musk, include L-Muscone)2020-08-10
    Drug · OTC · Notification202005722
  • MFDS drug로제케이정10/5밀리그램2020-06-23
    Drug · Prescription · Approval202004560
  • MFDS drug로제케이정10/10밀리그램2020-06-23
    Drug · Prescription · Approval202004561
  • MFDS drug로제케이정10/20밀리그램2020-06-23
    Drug · Prescription · Approval202004562
  • MFDS drugKwangdong Livershot Tab. 3002020-06-19
    Drug · OTC · Approval202004494
  • MFDS drugJanulow-D Tab. 25mg2020-05-29
    Drug · Prescription · Approval202004046
  • MFDS drugJanulow-D Tab. 50mg2020-05-29
    Drug · Prescription · Approval202004047
  • MFDS drugJanulow-D Tab. 100mg2020-05-29
    Drug · Prescription · Approval202004048
  • MFDS drug장이락캡슐(바실루스리케니포르미스균)2020-05-29
    Drug · OTC · Notification202004112
  • MFDS drugJangi Lac Powder2020-05-26
    Drug · OTC · Notification202003864
  • MFDS drugErinitor Tab. 5mg2020-03-31
    Drug · Prescription · Approval202002237
  • MFDS drugSencodyl F Tab.2020-02-05
    Drug · OTC · Notification202000645
  • MFDS drug광동탕엠액2019-12-26
    Drug · OTC · Notification201908635
  • MFDS drug티보리시정2.5밀리그램(티볼론)2019-12-19
    Drug · Prescription · Approval201908527
  • MFDS drugAmipartybag Inj. 5%2019-12-11
    Drug · Prescription · Notification201908353
  • MFDS drug뮤아렌정(에페리손염산염)Revoked2019-10-28
    Drug · Prescription · Approval201907489
  • MFDS drug광동알디액2019-10-18
    Drug · OTC · Notification201907347
  • MFDS drug비타민디3본주100,000IU(콜레칼시페롤)Revoked2019-09-18
    Drug · Prescription · Notification201906532
  • MFDS drug비타민디3본주300,000IU(콜레칼시페롤)Revoked2019-09-18
    Drug · Prescription · Notification201906533

Showing the 80 most recent of 321 records.

Clinical trials

data.go.kr

29 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 22 · Phase 1 4 · Phase 3 2 · Phase 2 1)

  • BioequivalenceKD-R1122026-05-28

    1 trial site

  • BioequivalenceKD-R1112025-08-20

    1 trial site

  • BioequivalenceKD-R1102025-03-27

    1 trial site

  • BioequivalenceKD-R109T2024-04-29

    1 trial site

  • Bioequivalence아디펙스정(펜터민염산염)2023-04-06

    2 trial sites

  • BioequivalenceKD-R105T2022-12-06

    1 trial site

  • BioequivalenceKD-R201T2022-09-29

    1 trial site

  • Bioequivalence알렌시캡슐125밀리그램2022-02-14

    1 trial site

  • Phase 3Vyleesi 주사제2020-05-22

    14 trial sites

  • Bioequivalence넥소닙정200밀리그램2020-04-24

    2 trial sites

  • Bioequivalence광동네비보롤염산염정5밀리그램(네비보롤염산염)2019-09-11

    2 trial sites

  • Bioequivalence광동아토르바스타틴정20밀리그램(아토르바스타틴칼슘삼수화물)2018-07-17

    2 trial sites

Show 17 more
  • Bioequivalence광동에베로리무스정5mg(가칭)2017-03-09

    2 trial sites

  • Bioequivalence에이덱스정(아나스트로졸)2017-01-17

    2 trial sites

  • Phase 2KD101 연질캡슐 200mg2016-10-27

    10 trial sites

  • Bioequivalence레날리도마이드25mg2016-10-11

    2 trial sites

  • Bioequivalence광동에베로리무스정(가칭)2016-08-23

    2 trial sites

  • Phase 1KD101 연질캡슐 200mg, 50mg2014-11-27

    1 trial site

  • Bioequivalence광동타다라필구강붕해필름10밀리그램 (Tadalafil 10mg)2014-11-20

    2 trial sites

  • Phase 1광동타다라필구강붕해필름20mg2014-06-10

    1 trial site

  • Bioequivalence광동타다라필구강붕해필름20mg (Tadalafil 20mg)2014-05-27

    2 trial sites

  • Phase 3비타민D3비오엔주(콜레칼시페롤)2013-11-13

    3 trial sites

  • Bioequivalence광동로라타딘구강붕해필름2013-07-31

    1 trial site

  • Phase 1KD101 연질캡슐 200mg2013-07-17

    1 trial site

  • Bioequivalence알도셉트구강붕해필름 10밀리그램(도네페질염산염)2013-05-30

    1 trial site

  • Bioequivalence광동타목시펜정2013-05-15

    2 trial sites

  • Bioequivalence광동타목시펜정20밀리그램2013-05-15

    2 trial sites

  • Bioequivalence광동테가푸르/기메라실/오테라실캡슐2012-10-08
  • Phase 1KD-ODF-012012-01-12

    1 trial site

Key disclosures

KRX KIND via OpenDART
Show 1 more events

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 111 more patents

AI reads

MAA server logs · IP-verified
92
Times AI engines pulled KWANGDONG PHARMACEUTICAL CO.,LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

91
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 0
Last 7 days
71
live 0
Last 30 days
92
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot81
  • PerplexityPerplexityBot4
  • GoogleGoogleOther3
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for KWANGDONG PHARMACEUTICAL CO.,LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · products · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

NanoenTek,Inc.2 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

HUMASIS CO., LTD.2 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

OSANG HEALTHCARE CO.,LTD.2 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

Sugentech, Inc.2 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

GC Medical Science Corporation2 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

Aprogen Biologics Inc.2 shared

Aprogen Biologics develops Remicade, Rituxan, and Herceptin biosimilars and operates a world top-5 scale antibody production facility.

DONG-A ST CO.,LTD2 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

SD BIOSENSOR INC.2 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

KYUNG NAM PHARM.CO.,LTD.1 shared

Founded in 1998, Kyungnam Pharm is a pharmaceutical and health-food company known for the vitamin brand Lemona and placenta drink Jahasaengryeok.

ChoA Pharmaceutical Co., LTD.1 shared

Founded in 1996 and listed on KOSDAQ in 1999, ChoA Pharmaceutical is an OTC-focused drugmaker exporting to 23 countries worldwide.

YUHAN CORPORATION1 shared

Founded in 1926 and listed on the KOSPI in 1962, Yuhan Corporation is a comprehensive pharmaceutical company known for its innovative drug Leclaza.

VIVOZON PHARMACEUTICAL CO., LTD.1 shared

Vivozon Pharmaceutical, founded in 2002 and KOSDAQ-listed in 2005, makes ETC/OTC drugs and runs CMO/OEM businesses across about 190 items.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition